Evidence-Based Practice project paper on diabetes

Answer

Evidence Based Practice in Treatment of Diabetes in Adults.

Klonoff, D. C., Ahn, D., & Drincic, A. (2017). Continuous Glucose Monitoring: A Review of the Technology and Clinical Use of CGM. Diabetes Research and Clinical Practice.

Nurses form a strong point of focus as far as medical care is concerned. When it comes to matters medical care, positive results are of great importance. In order to achieve these results, evidence-based practices are increasingly being encouraged within the health sector. Evidence- based practice (EBP) is a diverse concept whose importance is growing over time across all health care systems both in Unites States and on a global scale. According to A.T. Still University (011, para 1), evidence based practice is interpreted as performing right procedures for the right people at an appropriate time basing on best research evidence. Staying up-to-date with technological advancement and the most recent research or study findings in crucial for providing premium care within health organizations.

My essay seeks to comprehensively outline the most recognized research finding on a new diagnostic diabetes tool in adults. I will base this essay on the Evidence based   research study done by Klonoff, Ahn, and Drincic titled “Continuous glucose monitoring: A review of the technology and clinical use.” I will carry out an analysis of how the selected evidence will integrate philosophical standpoints identified to underpin the existing evidence as well as discussing evidence related implication for my practice. Moreover, I will apply the critiquing guidelines for qualitative research in developing a paper critique of my research.

Continuous glucose monitoring (CGM) is an adaptive technological skill for providing aid among insulin-requiring patients through provision of insights into glycemic fluctuations, creating efficiencies in managing diabetes through adjusting to healthy lifestyles and provision of quality medication. The article outlines an overview of clinical and technical SGM based features on article reviews published back then in PubMed on CGM, with a time range from 1999 till early 2017. There has been an intensive reviewing of outpatient outcomes of CGM which puts ore focus on hemoglobin AIC, quality of life and hypoglycemia. A vivid description of factors affecting detection of glycemic variability, cyber security, accuracies and strategies for optimal use has equally been developed. Basing on improved outcomes among type 1 diabetes mellitus patients, CGM is categorized as an important diabetes monitoring tool. This tool can also be considered for other issues among different populations considering the available technological developments and available data on the same.

A continuous glucose monitor is a type of wearable body sensor for continuously and automatically measuring glucose levels at intervals of every five to fifteen minutes time range within a defined body fluid like the interstitial fluids (ISF). It comprises of 3 components; receiver for displaying readings to users, a wearable sensor and a direct transmitter wirelessly sending detection messages to the receiver. The glycemic visualized patterns from CGM have been utilized by health-care professionals and patients for adjusting to medication and lifestyle changes while adjusting blood sugar level by use of a capillary glucose test.

The approved types of CGM utilize the enzymatic technology by reacting with the ISF glucose product molecules producing glucose molecule electrons which transfer oxygenated cofactors to electric current generated electrode. The current, which is proportional to glucose concentration, is thereafter relayed from a transmitter. This represents a wireless connection to the sensor or a computer device via a detective cable for displaying relevant personal data to the patient. It allows the reader display all results directly to the recipient (in this case a patient), or wirelessly send data to a patient’s HCP, patient’s cloud or an authorized care provider to allow data viewing on a computer within a secured personal website.

Glucose oxidase cofactors utilized by CGM react with available tissue oxygen leading to an overestimation of glucose concentration amount in issues relating to hypoxia. Remedy to this has been established through utilization of a cofactor and an enzyme that is not dependent upon oxygen to allow acceptance of electrons generated from glucose. The sensors referred to as secondary generations do not suffer the effects of hypoxemia though they contain toxic cofactors unsuitable for implantation. The latest sensors under development will not be dependent on cofactors for liberating electrons allowing implantation of oxygen independent sensors without toxicity issues nor reliance on ambient ISF Oxygen concentration. CGMs aim at improving diabetes outcome specifically hypoglycemia and the hemoglobin A1C. There has been a considerable improvement in A1C with a mild decrease in hypoglycemia incidences.

In conclusion, CGMs are very crucial tools for diabetes monitoring. With the ever-changing technological skills, they are becoming easily applicable showing accuracy levels. CGM offers unique and helpful features like change information rates detectors, data on glucose trends in body system and timely alerts for risky glycemic events. The usefulness of these monitory tools has been diversified by sensor integrated pump alongside the sensor augmented pump. This clearly depicts CGM’s evolution over time up-to standardization as a quality tool for diabetes management in a wide populations range(2017) study employed, there are very little room for generalizing the study’s findings.